Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Anemia

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 64 articles:
HTML format



Single Articles


    June 2024
  1. LONGVAL T, Lepretre AC, Ravinet A, Fayard A, et al
    Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC.
    Bone Marrow Transplant. 2024;59:893-895.
    PubMed    


    May 2024
  2. VASSEUR L, Cuffel A, Pondarre C, Dalle JH, et al
    Early lymphocyte reconstitution and viral infections in adolescents and adults transplanted for sickle cell disease.
    Bone Marrow Transplant. 2024;59:708-710.
    PubMed    


    April 2024
  3. ZHANG X, Zhao X, Chen S, Hao M, et al
    Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients.
    Bone Marrow Transplant. 2024 Apr 5. doi: 10.1038/s41409-024-02266.
    PubMed     Abstract available


  4. CIANGOLA G, Santinelli E, McLornan DP, Pagliuca S, et al
    Diagnostic evaluation in bone marrow failure disorders: what have we learnt to help inform the transplant decision in 2024 and beyond?
    Bone Marrow Transplant. 2024;59:444-450.
    PubMed     Abstract available


    March 2024
  5. JO T, Arai Y, Kitawaki T, Nakamura N, et al
    KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresis.
    Bone Marrow Transplant. 2024;59:419-421.
    PubMed    


    February 2024
  6. YAMAMOTO R, Hiramoto N, Fujimoto A, Yamazaki H, et al
    Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2024 Feb 10. doi: 10.1038/s41409-024-02234.
    PubMed    


  7. MEISSNER B, Lang P, Bader P, Hoenig M, et al
    Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression.
    Bone Marrow Transplant. 2024 Feb 7. doi: 10.1038/s41409-024-02219.
    PubMed     Abstract available


    January 2024
  8. GREENMYER JR, Ariagno S, Ali A, Pence L, et al
    Autoimmune cytopenias following pediatric hematopoietic cell transplant.
    Bone Marrow Transplant. 2024;59:117-120.
    PubMed    


    December 2023
  9. GABELLI M, Perez-Martinez A, Bueno Sanchez D, Lucchini G, et al
    Abatacept treatment for autoimmune hemolytic anemia occurring post hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2023 Dec 14. doi: 10.1038/s41409-023-02173.
    PubMed    


    October 2023
  10. AYAS M, Al-Hashim F, Siddiqui K, Al-Jefri A, et al
    Hematopoietic stem cell transplantation in patients with Fanconi anemia: a report of late effects and psychosocial adjustment in life.
    Bone Marrow Transplant. 2023 Oct 25. doi: 10.1038/s41409-023-02133.
    PubMed    


  11. CANCIO M, Troullioud Lucas AG, Bierings M, Klein E, et al
    Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia.
    Bone Marrow Transplant. 2023 Oct 17. doi: 10.1038/s41409-023-02121.
    PubMed     Abstract available


    September 2023
  12. SATTY AM, Klein E, Mauguen A, Kunvarjee B, et al
    T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.
    Bone Marrow Transplant. 2023 Sep 29. doi: 10.1038/s41409-023-02113.
    PubMed     Abstract available


    August 2023
  13. ROSSI M, Szepetowski S, Yakouben K, Paillard C, et al
    Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of St
    Bone Marrow Transplant. 2023 Aug 4. doi: 10.1038/s41409-023-02079.
    PubMed    


    July 2023
  14. XU ZL, Xu LP, Zhang YY, Cheng YF, et al
    Mixed chimaerism is associated with poorer long-term failure-free survival among aplastic anaemia patients receiving HLA-matched donor transplantation.
    Bone Marrow Transplant. 2023;58:832-834.
    PubMed    


    April 2023
  15. GOMEZ-ARTEAGA A, Orfali N, Pasciolla M, Baptiste A, et al
    Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
    Bone Marrow Transplant. 2023 Apr 12. doi: 10.1038/s41409-023-01981.
    PubMed    


    January 2023
  16. KATSUYA H, Yamaguchi K, Dung TC, Sano H, et al
    Late graft failure with donor-derived GPI-deficient cells in a mixed chimera following allogeneic bone marrow transplantation for severe aplastic anemia.
    Bone Marrow Transplant. 2023 Jan 21. doi: 10.1038/s41409-023-01923.
    PubMed    


    November 2022
  17. KHARYA G, Sapkota S, Teotia N, Chaudhary M, et al
    Thiotepa-based reduced toxicity conditioning in combination with post-transplant cyclophosphamide and mTOR inhibitor for heavily transfused acquired severe aplastic anemia in children and young adults: encouraging outcomes of a pilot study.
    Bone Marrow Transplant. 2022 Nov 24. doi: 10.1038/s41409-022-01876.
    PubMed    


  18. SANTARONE S, Angelini S, Natale A, Vaddinelli D, et al
    Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major.
    Bone Marrow Transplant. 2022;57:1689-1697.
    PubMed     Abstract available


    October 2022
  19. XU L, Lu Y, Chen J, Sun S, et al
    Fludarabine- and low-dose cyclophosphamide-based conditioning regimens provided favorable survival and engraftment for unmanipulated hematopoietic cell transplantation from unrelated donors and matched siblings in patients with Fanconi anemia: results
    Bone Marrow Transplant. 2022 Oct 18. pii: 10.1038/s41409-022-01838.
    PubMed    


    September 2022
  20. MULAS O, Caocci G, Efficace F, Piras E, et al
    Long-term health-related quality of life in patients with beta-thalassemia after unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Sep 16. pii: 10.1038/s41409-022-01823.
    PubMed    


    July 2022
  21. PRABAHRAN A, Koldej R, Chee L, Szer J, et al
    Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review.
    Bone Marrow Transplant. 2022 Jul 23. pii: 10.1038/s41409-022-01761.
    PubMed     Abstract available


  22. RANGARAJAN HG, Crowell SA, Towerman AS, Shenoy SS, et al
    CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease.
    Bone Marrow Transplant. 2022 Jul 7. pii: 10.1038/s41409-022-01749.
    PubMed    


  23. XU LP, Xu ZL, Zhang YY, Cheng YF, et al
    Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia.
    Bone Marrow Transplant. 2022;57:1204-1206.
    PubMed    


    June 2022
  24. TANG L, Wu Y, Lei R, Liu J, et al
    Adding 5-day decitabine to the conditioning regimen for haploidentical bone marrow transplantation in aplastic anaemia patients results in satisfactory clinical outcomes.
    Bone Marrow Transplant. 2022 Jun 22. pii: 10.1038/s41409-022-01729.
    PubMed    


    April 2022
  25. LIANG H, Pan L, Xie Y, Fan J, et al
    Health-related quality of life in pediatric patients with beta-thalassemia major after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Apr 29. pii: 10.1038/s41409-022-01663.
    PubMed     Abstract available


    February 2022
  26. YESILIPEK MA, Uygun V, Kupesiz A, Karasu G, et al
    Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience.
    Bone Marrow Transplant. 2022 Feb 24. pii: 10.1038/s41409-022-01613.
    PubMed     Abstract available


  27. ARSLAN S, Ali H, Mei M, Marcucci G, et al
    Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib.
    Bone Marrow Transplant. 2022 Feb 22. pii: 10.1038/s41409-022-01590.
    PubMed    


  28. PARSONS SK, Rodday AM, Weidner RA, Morris E, et al
    Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant.
    Bone Marrow Transplant. 2022 Feb 2. pii: 10.1038/s41409-022-01584.
    PubMed     Abstract available


  29. DAMLAJ M, Alahmari B, Alaskar A, Alhejazi A, et al
    Feasibility of early sirolimus cessation post non-myeloablative transplantation in adult patients with severe sickle cell disease.
    Bone Marrow Transplant. 2022;57:319-322.
    PubMed    


    December 2021
  30. IFTIKHAR R, Ahmad P, de Latour R, Dufour C, et al
    Correction to: Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group and Severe Aplasti
    Bone Marrow Transplant. 2021 Dec 20. pii: 10.1038/s41409-021-01534.
    PubMed    


  31. OIKONOMOPOULOU C, Goussetis E
    HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe.
    Bone Marrow Transplant. 2021;56:2882-2888.
    PubMed     Abstract available


    November 2021
  32. HASHEM H, Rihani R, Shanap MA, Khattab E, et al
    Novel conditioning regimen for upfront haploidentical hematopoietic cell transplantation in children with severe aplastic anemia and donor-specific anti-HLA antibodies.
    Bone Marrow Transplant. 2021 Nov 27. pii: 10.1038/s41409-021-01536.
    PubMed    


  33. ROVO A, Tichelli A
    Cancers after hematopoietic cell transplantation for aplastic anemia-the importance of persistence.
    Bone Marrow Transplant. 2021 Nov 9. pii: 10.1038/s41409-021-01514.
    PubMed    


  34. ALZAHRANI M, Damlaj M, Essa M, Alahmari B, et al
    HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome.
    Bone Marrow Transplant. 2021 Nov 6. pii: 10.1038/s41409-021-01513.
    PubMed    


  35. JOHN TD, Friend B, Yassine K, Sasa G, et al
    Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience.
    Bone Marrow Transplant. 2021;56:2797-2803.
    PubMed     Abstract available


    October 2021
  36. MARTINO R, Garcia-Cadenas I, Esquirol A
    Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation.
    Bone Marrow Transplant. 2021 Oct 28. pii: 10.1038/s41409-021-01507.
    PubMed    


  37. VO P, Onstad L, Flowers ME, Storb R, et al
    Cancers after HLA-matched related bone marrow transplantation for aplastic anemia.
    Bone Marrow Transplant. 2021 Oct 16. pii: 10.1038/s41409-021-01498.
    PubMed     Abstract available


  38. DEBUREAUX PE, Kulasekararaj AG, Cacace F, Silva BGP, et al
    Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study.
    Bone Marrow Transplant. 2021;56:2600-2602.
    PubMed    


    September 2021
  39. ABUELGASIM KA, Damlaj M, Bosaeed M, Altamimi S, et al
    Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Sep 10. pii: 10.1038/s41409-021-01457.
    PubMed    


    August 2021
  40. DIAZ-DE-HEREDIA C, Bresters D, Faulkner L, Yesilipek A, et al
    Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT.
    Bone Marrow Transplant. 2021 Aug 31. pii: 10.1038/s41409-021-01449.
    PubMed     Abstract available


  41. AKDOGAN N, Ersoy-Evans S, Visal Okur F, Kuskonmaz B, et al
    Long-term skin findings in patients with Fanconi anemia after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Aug 27. pii: 10.1038/s41409-021-01441.
    PubMed    


  42. SINGH AK, Schetzen E, Yadav SK, Lustig EB, et al
    Correction of murine sickle cell disease by allogeneic haematopoietic cell transplantation with anti-3rd party veto cells.
    Bone Marrow Transplant. 2021;56:1818-1827.
    PubMed     Abstract available


    July 2021
  43. BLENNERHASSETT R, Moses JH, Coulits N, Horne A, et al
    Recurrent secondary graft failure likely due to a DRB4 donor-specific antibody in a patient with aplastic anemia and DRB4 null allele.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01402.
    PubMed    


  44. SOCIE G, Peffault de Latour R
    Secondary malignancies after transplantation for aplastic anemia.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01400.
    PubMed    


  45. COSTA TCM, Chiari-Correia R, Salmon CEG, Darrigo-Junior LG, et al
    Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01365.
    PubMed     Abstract available


  46. LIU L, Miao M, Chen X, Zhang Y, et al
    Outcomes of severe aplastic anemia patients with infection proceeding with allogeneic hematopoietic stem cell transplantation, versus patients without infection.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01398.
    PubMed    


    June 2021
  47. IFTIKHAR R, Chaudhry QN, Mahmood SK, Ghafoor T, et al
    A novel TBI free conditioning protocol for haploidentical transplant in acquired aplastic anemia: (FluCAB-Prime).
    Bone Marrow Transplant. 2021 Jun 25. pii: 10.1038/s41409-021-01385.
    PubMed    


    May 2021
  48. IFTIKHAR R, Ahmad P, de Latour R, Dufour C, et al
    Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia workin
    Bone Marrow Transplant. 2021 May 19. pii: 10.1038/s41409-021-01332.
    PubMed     Abstract available


  49. FRIEDMAN D, Dozor AJ, Milner J, D'Souza M, et al
    Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2021 May 6. pii: 10.1038/s41409-021-01298.
    PubMed     Abstract available


    February 2021
  50. MISKIEWICZ-BUJNA J, Miskiewicz-Migon I, Panasiuk A, Kubica-Cielinska A, et al
    Severe and fatal toxicity after hematopoietic stem cell transplantation in GNE defect-associated thrombocytopenia.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01235.
    PubMed    


  51. LAI X, Liu L, Zhang Z, Shi L, et al
    Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
    Bone Marrow Transplant. 2021 Feb 19. pii: 10.1038/s41409-021-01233.
    PubMed     Abstract available


  52. KHARYA G, Bakane A, Agarwal S, Rauthan A, et al
    Pre-transplant myeloid and immune suppression, upfront plerixafor mobilization and post-transplant cyclophosphamide: novel strategy for haploidentical transplant in sickle cell disease.
    Bone Marrow Transplant. 2021;56:492-504.
    PubMed     Abstract available


    December 2020
  53. XU ZL, Huang XJ
    Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01169.
    PubMed     Abstract available


  54. MURILLO-SANJUAN L, Gonzalez-Vicent M, Argiles Aparicio B, Badell Serra I, et al
    Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
    Bone Marrow Transplant. 2020 Dec 10. pii: 10.1038/s41409-020-01172.
    PubMed     Abstract available


    November 2020
  55. MARCO-AYALA J, Gomez-Segui I, Sanz G, Solves P, et al
    Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.
    Bone Marrow Transplant. 2020 Nov 14. pii: 10.1038/s41409-020-01124.
    PubMed     Abstract available


    October 2020
  56. KOYAMAISHI S, Kamio T, Kobayashi A, Sato T, et al
    Correction: Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia.
    Bone Marrow Transplant. 2020 Oct 14. pii: 10.1038/s41409-020-01076.
    PubMed     Abstract available


    May 2020
  57. YOSHIDA N, Takahashi Y, Yabe H, Kobayashi R, et al
    Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0948.
    PubMed     Abstract available


    March 2020
  58. GLUCKMAN E, Fuente J, Cappelli B, Scigliuolo GM, et al
    The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
    Bone Marrow Transplant. 2020 Mar 10. pii: 10.1038/s41409-020-0847.
    PubMed     Abstract available


    January 2020
  59. LIU L, Zhang Y, Liu S, Zhou H, et al
    Outcomes of conditioning with rabbit antithymocyte globulin and rituximab in haploidentical haematopoietic stem cell transplantation in patients with severe aplastic anaemia.
    Bone Marrow Transplant. 2020 Jan 20. pii: 10.1038/s41409-020-0788.
    PubMed    


    November 2019
  60. LIU L, Zhang Y, Liu S, Zhou H, et al
    Outcomes of haploidentical haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0751.
    PubMed    


    September 2019
  61. MARWAH P, Soni R, Ramprakash S, Raghuram CP, et al
    The impact of Host vs. Graft mismatches on rejection of haploidentical bone marrow transplants in thalassemia patients using posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2019 Sep 30. pii: 10.1038/s41409-019-0692.
    PubMed    


  62. MILLER PDE, Snowden JA, De Latour RP, Iacobelli S, et al
    Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and
    Bone Marrow Transplant. 2019 Sep 25. pii: 10.1038/s41409-019-0680.
    PubMed     Abstract available


  63. RAUTENBERG C, Kaivers J, Germing U, Haas R, et al
    Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 3. pii: 10.1038/s41409-019-0664.
    PubMed    


    May 2019
  64. KATOH D, Ochi Y, Hiramoto N, Morita M, et al
    Parvovirus B19 infection in adult patients after allogeneic stem cell transplantation: our experience of five cases and literature review.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0533.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.